{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:20:03Z","timestamp":1792851603610,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005878","name":"Terveyden Tutkimuksen Toimikunta","doi-asserted-by":"publisher","award":["294817"],"award-info":[{"award-number":["294817"]}],"id":[{"id":"10.13039\/501100005878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","award":["TYH2018217"],"award-info":[{"award-number":["TYH2018217"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010116","name":"Medicinska Underst\u00f6dsf\u00f6reningen Liv och H\u00e4lsa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00401-019-02071-3","type":"journal-article","created":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T11:02:51Z","timestamp":1567854171000},"page":"771-782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Lewy-related pathology exhibits two anatomically and genetically distinct progression patterns: a population-based study of Finns aged 85+"],"prefix":"10.1007","volume":"138","author":[{"given":"Anna","family":"Raunio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karri","family":"Kaivola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarno","family":"Tuimala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Kero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Oinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomo","family":"Polvikoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Paetau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pentti J.","family":"Tienari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2237-5466","authenticated-orcid":false,"given":"Liisa","family":"Myllykangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,7]]},"reference":[{"key":"2071_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00401-009-0523-2","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I et al (2009) Staging\/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:635\u2013652. \n                    https:\/\/doi.org\/10.1007\/s00401-009-0523-2","journal-title":"Acta Neuropathol"},{"key":"2071_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0006-8993(00)03082-1","volume":"888","author":"Y Arai","year":"2001","unstructured":"Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y (2001) Alpha-synuclein-positive structures in cases with sporadic Alzheimer\u2019s disease: morphology and its relationship to tau aggregation. Brain Res 888:287\u2013296","journal-title":"Brain Res"},{"key":"2071_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL et al (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689\u2013702. \n                    https:\/\/doi.org\/10.1007\/s00401-010-0664-3","journal-title":"Acta Neuropathol"},{"key":"2071_CR4","doi-asserted-by":"publisher","first-page":"e1004606","DOI":"10.1371\/journal.pgen.1004606","volume":"10","author":"GW Beecham","year":"2014","unstructured":"Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ et al (2014) Genome-wide association meta-analysis of neuropathologic features of Alzheimer\u2019s disease and related dementias. PLoS Genet 10:e1004606. \n                    https:\/\/doi.org\/10.1371\/journal.pgen.1004606","journal-title":"PLoS Genet"},{"key":"2071_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"2071_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"2071_CR7","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","volume":"23","author":"J Bras","year":"2014","unstructured":"Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG et al (2014) Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet 23:6139\u20136146. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddu334","journal-title":"Hum Mol Genet"},{"key":"2071_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00441-017-2733-6","volume":"373","author":"MG Cersosimo","year":"2018","unstructured":"Cersosimo MG (2018) Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies. Cell Tissue Res 373:233\u2013243. \n                    https:\/\/doi.org\/10.1007\/s00441-017-2733-6","journal-title":"Cell Tissue Res"},{"key":"2071_CR9","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1212\/wnl.0000000000006212","volume":"91","author":"DW Dickson","year":"2018","unstructured":"Dickson DW, Heckman MG, Murray ME, Soto AI, Walton RL, Diehl NN et al (2018) APOE \u03b54 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology 91:e1182\u2013e1195. \n                    https:\/\/doi.org\/10.1212\/wnl.0000000000006212","journal-title":"Neurology"},{"key":"2071_CR10","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1212\/WNL.41.9.1402","volume":"41","author":"DW Dickson","year":"1991","unstructured":"Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y et al (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer\u2019s disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 41:1402\u20131409","journal-title":"Neurology"},{"issue":"Suppl 1","key":"2071_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/mds.22637","volume":"25","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y (2010) Evidence in favor of Braak staging of Parkinson\u2019s disease. Mov Disord 25(Suppl 1):78. \n                    https:\/\/doi.org\/10.1002\/mds.22637","journal-title":"Mov Disord"},{"key":"2071_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028035.a028035","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW (2017) Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a028035.a028035","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2071_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/NEN.0b013e31817d7a1d","volume":"67","author":"H Fujishiro","year":"2008","unstructured":"Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ et al (2008) Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 67:649\u2013656. \n                    https:\/\/doi.org\/10.1097\/NEN.0b013e31817d7a1d","journal-title":"J Neuropathol Exp Neurol"},{"key":"2071_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H (2013) 100\u00a0years of Lewy pathology. Nat Rev Neurol 9:13\u201324. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2012.242","journal-title":"Nat Rev Neurol"},{"key":"2071_CR15","doi-asserted-by":"publisher","first-page":"214.e7","DOI":"10.1016\/j.neurobiolaging.2015.10.028","volume":"38","author":"R Guerreiro","year":"2016","unstructured":"Guerreiro R, Escott-Price V, Darwent L, Parkkinen L, Ansorge O, Hernandez DG, Nalls MA et al (2016) Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson\u2019s and Alzheimer\u2019s diseases. Neurobiol Aging 38:214.e7\u2013214.e10. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.10.028","journal-title":"Neurobiol Aging"},{"key":"2071_CR16","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.nbd.2019.04.004","volume":"127","author":"R Guerreiro","year":"2019","unstructured":"Guerreiro R, Escott-Price V, Hernandez DG, Kun-Rodrigues C, Ross OA, Orme T et al (2019) Heritability and genetic variance of dementia with Lewy bodies. Neurobiol Dis 127:492\u2013501. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2019.04.004","journal-title":"Neurobiol Dis"},{"key":"2071_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s1474-4422(17)30400-3","volume":"17","author":"R Guerreiro","year":"2018","unstructured":"Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD et al (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64\u201374. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(17)30400-3","journal-title":"Lancet Neurol"},{"key":"2071_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","volume":"10","author":"RL Hamilton","year":"2000","unstructured":"Hamilton RL (2000) Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10:378\u2013384","journal-title":"Brain Pathol"},{"key":"2071_CR19","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005072-199710000-00002","volume":"56","author":"BT Hyman","year":"1997","unstructured":"Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095\u20131097. \n                    https:\/\/doi.org\/10.1097\/00005072-199710000-00002","journal-title":"J Neuropathol Exp Neurol"},{"key":"2071_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX et al (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16:55\u201365. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(16)30291-5","journal-title":"Lancet Neurol"},{"key":"2071_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","volume":"125","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA (2018) Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies. J Neural Transm (Vienna) 125:615\u2013650. \n                    https:\/\/doi.org\/10.1007\/s00702-017-1821-9","journal-title":"J Neural Transm (Vienna)"},{"key":"2071_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/(sici)1097-0266(199606)17:6<441::Aid-smj819>3.0.Co;2-g","volume":"17","author":"DJ Ketchen","year":"1996","unstructured":"Ketchen DJ, Shook CL (1996) The application of cluster analysis in strategic management research: an analysis and critique. Strateg Manag J 17:441\u2013458. \n                    https:\/\/doi.org\/10.1002\/(sici)1097-0266(199606)17:6%3c441:Aid-smj819%3e3.0.Co;2-g","journal-title":"Strateg Manag J"},{"key":"2071_CR23","first-page":"185","volume":"3","author":"K Kosaka","year":"1984","unstructured":"Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree\u2014a new disease? Clin Neuropathol 3:185\u2013192","journal-title":"Clin Neuropathol"},{"key":"2071_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.nbd.2014.05.020","volume":"69","author":"GG Kovacs","year":"2014","unstructured":"Kovacs GG, Breydo L, Green R, Kis V, Puska G, Lorincz P et al (2014) Intracellular processing of disease-associated alpha-synuclein in the human brain suggests prion-like cell-to-cell spread. Neurobiol Dis 69:76\u201392. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2014.05.020","journal-title":"Neurobiol Dis"},{"key":"2071_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-012-0964-x","volume":"124","author":"GG Kovacs","year":"2012","unstructured":"Kovacs GG, Wagner U, Dumont B, Pikkarainen M, Osman AA, Streichenberger N et al (2012) An antibody with high reactivity for disease-associated alpha-synuclein reveals extensive brain pathology. Acta Neuropathol 124:37\u201350. \n                    https:\/\/doi.org\/10.1007\/s00401-012-0964-x","journal-title":"Acta Neuropathol"},{"key":"2071_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/s1474-4422(05)70219-2","volume":"4","author":"I McKeith","year":"2005","unstructured":"McKeith I, Cummings J (2005) Behavioural changes and psychological symptoms in dementia disorders. Lancet Neurol 4:735\u2013742. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(05)70219-2","journal-title":"Lancet Neurol"},{"key":"2071_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88\u2013100. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"key":"2071_CR28","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863\u20131872. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000187889.17253.b1","journal-title":"Neurology"},{"key":"2071_CR29","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113\u20131124","journal-title":"Neurology"},{"key":"2071_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"2071_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10:785\u2013796. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(11)70156-9","journal-title":"Lancet Neurol"},{"key":"2071_CR32","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/1531-8249(199909)46:3<382::AID-ANA14>3.0.CO;2-5","volume":"46","author":"L Myllykangas","year":"1999","unstructured":"Myllykangas L, Polvikoski T, Sulkava R, Verkkoniemi A, Crook R, Tienari PJ et al (1999) Genetic association of alpha2-macroglobulin with Alzheimer\u2019s disease in a Finnish elderly population. Ann Neurol 46:382\u2013390","journal-title":"Ann Neurol"},{"key":"2071_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3233\/JAD-2009-1169","volume":"18","author":"M Oinas","year":"2009","unstructured":"Oinas M, Polvikoski T, Sulkava R, Myllykangas L, Juva K, Notkola IL et al (2009) Neuropathologic findings of dementia with Lewy bodies (DLB) in a population-based Vantaa 85+ study. J Alzheimers Dis 18:677\u2013689. \n                    https:\/\/doi.org\/10.3233\/JAD-2009-1169","journal-title":"J Alzheimers Dis"},{"key":"2071_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D et al (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:5. \n                    https:\/\/doi.org\/10.1186\/s13024-019-0306-8","journal-title":"Mol Neurodegener"},{"key":"2071_CR35","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/acn3.231","volume":"2","author":"T Peuralinna","year":"2015","unstructured":"Peuralinna T, Myllykangas L, Oinas M, Nalls MA, Keage HA, Isoviita VM et al (2015) Genome-wide association study of neocortical Lewy-related pathology. Ann Clin Transl Neurol 2:920\u2013931. \n                    https:\/\/doi.org\/10.1002\/acn3.231","journal-title":"Ann Clin Transl Neurol"},{"key":"2071_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3233\/JAD-2011-102049","volume":"26","author":"T Peuralinna","year":"2011","unstructured":"Peuralinna T, Tanskanen M, M\u00e4kel\u00e4 M, Polvikoski T, Paetau A, Kalimo H et al (2011) APOE and A\u03b2PP gene variation in cortical and cerebrovascular amyloid-\u03b2 pathology and Alzheimer\u2019s disease: a population-based analysis. J Alzheimers Dis 26:377\u2013385. \n                    https:\/\/doi.org\/10.3233\/JAD-2011-102049","journal-title":"J Alzheimers Dis"},{"key":"2071_CR37","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1212\/WNL.56.12.1690","volume":"56","author":"T Polvikoski","year":"2001","unstructured":"Polvikoski T, Sulkava R, Myllykangas L, Notkola IL, Niinisto L, Verkkoniemi A et al (2001) Prevalence of Alzheimer\u2019s disease in very elderly people: a prospective neuropathological study. Neurology 56:1690\u20131696","journal-title":"Neurology"},{"key":"2071_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-014-0082-1","author":"J Rahimi","year":"2014","unstructured":"Rahimi J, Kovacs GG (2014) Prevalence of mixed pathologies in the aging brain. Alzheimers Res Ther. \n                    https:\/\/doi.org\/10.1186\/s13195-014-0082-1","journal-title":"Alzheimers Res Ther"},{"key":"2071_CR39","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3233\/JAD-170104","volume":"58","author":"A Raunio","year":"2017","unstructured":"Raunio A, Myllykangas L, Kero M, Polvikoski T, Paetau A, Oinas M (2017) Amygdala alpha-synuclein pathology in the population-based Vantaa 85+ study. J Alzheimers Dis 58:669\u2013674. \n                    https:\/\/doi.org\/10.3233\/JAD-170104","journal-title":"J Alzheimers Dis"},{"key":"2071_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.nbd.2019.02.016","volume":"127","author":"MS Sabir","year":"2019","unstructured":"Sabir MS, Blauwendraat C, Ahmed S, Serrano GE, Beach TG, Perkins M et al (2019) Assessment of APOE in atypical parkinsonism syndromes. Neurobiol Dis 127:142\u2013146. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2019.02.016","journal-title":"Neurobiol Dis"},{"key":"2071_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S et al (2016) Pathological \u03b1-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology. Acta Neuropathol 131:393\u2013409. \n                    https:\/\/doi.org\/10.1007\/s00401-015-1526-9","journal-title":"Acta Neuropathol"},{"key":"2071_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","volume":"70","author":"D Tsuang","year":"2013","unstructured":"Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA et al (2013) APOE \u03b54 increases risk for dementia in pure synucleinopathies. JAMA Neurol 70:223\u2013228. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2013.600","journal-title":"JAMA Neurol"},{"key":"2071_CR43","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","volume":"65","author":"H Uchikado","year":"2006","unstructured":"Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685\u2013697. \n                    https:\/\/doi.org\/10.1097\/01.jnen.0000225908.90052.07","journal-title":"J Neuropathol Exp Neurol"},{"key":"2071_CR44","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2014","unstructured":"Vann Jones SA, O\u2019Brien JT (2014) The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med 44:673\u2013683. \n                    https:\/\/doi.org\/10.1017\/S0033291713000494","journal-title":"Psychol Med"},{"key":"2071_CR45","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","volume":"386","author":"Z Walker","year":"2015","unstructured":"Walker Z, Possin KL, Boeve BF, Aarsland D (2015) Lewy body dementias. Lancet 386:1683\u20131697. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(15)00462-6","journal-title":"Lancet"},{"key":"2071_CR46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrneurol.2017.63","volume":"13","author":"Y-T Wu","year":"2017","unstructured":"Wu Y-T, Beiser AS, Breteler MMB, Fratiglioni L, Helmer C, Hendrie HC et al (2017) The changing prevalence and incidence of dementia over time\u2013current evidence. Nat Rev Neurol 13:327\u2013339. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2017.63","journal-title":"Nat Rev Neurol"},{"key":"2071_CR47","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","volume":"70","author":"J Zaccai","year":"2008","unstructured":"Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG (2008) Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 70:1042\u20131048. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000306697.48738.b6","journal-title":"Neurology"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02071-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-019-02071-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02071-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T00:38:23Z","timestamp":1599352703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-019-02071-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,7]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2071"],"URL":"https:\/\/doi.org\/10.1007\/s00401-019-02071-3","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,7]]},"assertion":[{"value":"26 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Pentti J. Tienari holds patent on C9orf72 in diagnostics and treatment of ALS\/FTD and has made paid consultations to Roche, Biogen, Merck, Teva, Sanofi-Genzyme and Novartis. Other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants or their relatives.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}